B. L. Feringa, G. Roelfes et al.
These differences can be rationalized by considering that
the catalyzed reaction can take place in different microen-
vironments depending on the type of ligand used. The gen-
eral design of the catalysts comprises a metal-binding
domain and a DNA-binding domain to anchor the catalyst
to the DNA. In the second generation of catalysts, which
comprises planar, symmetric polyaromatic molecules, the
DNA binding moiety is integrated into the metal binding
site. Therefore, the catalytic metal center is most likely very
close to the DNA helix and the distance from the DNA de-
creases on going from larger, for example, dipyrido[3,2-
a:2’,3’-c]phenazine (dppz), to smaller polyaromatic moieties
such as bpy and dmbpy. It has been proposed that with the
catalysts based on the bpy-type ligands, the Diels–Alder re-
action takes place in the DNA groove, which provides a
chiral environment that is potentially structurally compatible
with the transition state of the reaction.[29] The resulting sta-
bilization of the transition state would explain the observed
58-fold rate enhancement and the high enantioselectivity
that was found with Cu–dmpby. This requires a specific
structure of the DNA groove, as demonstrated by the strong
DNA-sequence dependence of the enantioselectivity of the
reaction, which was shown to be positively affected by se-
quences containing guanine tracts, which give rise to B-
DNA, but with A-DNA characteristics.
bination of the structure of the ligand, which is supported
by the fact that both enantiomers of the product can be ac-
cessed depending on the design of the ligand, and the inter-
action of the DNA with the substrate-bound complex.
Conclusions
A detailed study of the first generation of DNA-based cata-
lysts in copper-catalyzed Diels–Alder reactions in water was
performed with a particular focus on establishing the role of
DNA in catalyzed enantioselective Diels–Alder reactions. A
comparison with the second generation of DNA-based cata-
lysts, which involves bpy-type ligands, revealed marked dif-
ferences, which are most likely the result of different micro-
environments for the catalyzed reactions. These findings un-
derline the fact that the design of the ligand is an important
aspect in the development of hybrid catalysts: Depending
on the ligand used, the catalyzed reactions can take place in
very different microenvironments, which results in different
reaction rates and enantioselectivities.
Experimental Section
In the first generation of ligands, the DNA binding
moiety, that is, 9-aminoacridine, is linked to a metal-binding
domain through a spacer. Hence, the catalyzed reaction is in
this case expected to take place at the edge of the DNA
groove and, therefore, will more resemble the reaction as it
occurs in solution in the absence of DNA. As a result only
small differences in reaction rate are observed between the
reactions with and without DNA. Furthermore, the enantio-
selectivity does not originate from the structural compatibil-
ity of the DNA groove with one enantiomer of the transi-
tion state, but most likely by the shielding of one face of the
enone by the arylmethyl side-chain of the ligand, as has also
been suggested for the enantioselective Diels–Alder reac-
tion catalyzed by copper–amino acid complexes.[34] The in-
teraction of the ligand with the substrate has been proposed
to occur by p–p stacking interactions. This hypothesis im-
plies that, in contrast to the bpy-based catalysts, with the
first generation of DNA-based catalysts the chirality is not
transferred directly from the DNA to the catalyzed reaction.
Instead, the chirality is transferred in two steps; the DNA
forces a chiral conformation on the bound copper complex,
which is in turn translated into enantioselective bond forma-
tion in the catalyzed Diels–Alder reaction. Indeed, the in-
duced CD effects, in particular the observed exciton cou-
pling, demonstrate that the DNA can enforce a chiral struc-
ture on the copper complex, even though the observed in-
duced CD effect proved to be unrelated to the enantiomeric
preference of the reaction. Based on the results obtained by
varying the substrates, we hypothesize that an important
aspect in determining which enantiomer is formed in excess
is whether the substrate binds in the cisoid or transoid con-
formation. This is in turn most likely determined by a com-
General: st-DNA was obtained from Sigma, pAT and pGC were obtained
from Amersham. Synthetic oligonucleotides were obtained from BioTez
(Germany). Cyclopentadiene was freshly prepared from its dimer prior
to use. Azachalcone dienophiles and acridine-based ligands (L1–L4)
were prepared by following published procedures.[35] For kinetic studies
st-DNA was dialyzed extensively against MES buffer (20 mm, pH 5.5)
prior to use. 1H and 13C NMR spectra were recorded on a Varian 400
(400 MHz) spectrometer in CDCl3. Chemical shifts (d) are given in ppm
using residual solvent as the internal standard (dC =77.0 ppm and dH =
7.26 ppm for CDCl3).
Physical methods—General: Circular Dichroism spectra were measured
on a JASCO J-715 spectropolarimeter equipped with a temperature con-
trol attachment. The UV/Vis spectra were measured on JASCO V-560
and JASCO V-570 spectrophotometers. The ees were determined by
HPLC analysis performed on a Shimadzu 10AD-VP system equipped
with a Daicel ODH column (n-heptane/iPrOH, 98:2, 0.5 mLminꢁ1) or a
Daicel OD column (n-heptane/iPrOH, 98:2, 1 mLminꢁ1).
Representative procedure for the [Cu(L)ACTHNUTRGNEUNG(NO3)2]/DNA-catalyzed Diels–
Alder cycloaddition reaction:
A solution of st-DNA (10 mL of a
2 mgmLꢁ1 solution of st-DNA dissolved in 30 mm MOPS buffer, pH 6.5,
and prepared 24 h in advance) was added to a catalyst solution of
[Cu(L)ACHTNUGTRNEUGN(NO3)2] (0.9 mm of Cu and 1.17 mm of ligand in a total volume of
5 mL) to a final concentration of 1.3 mgmLꢁ1. An aliquot of a stock solu-
tion of dienophile azachalcone in CH3CN (0.5m, 30 mL) was added to
obtain a final concentration of 1 mm and the mixture was subsequently
cooled to 58C. The reaction was started by the addition of cyclopenta-
diene (20 mL, 0.016m final concentration) and allowed to continue for 3 d
at 58C, while mixing continuously. The product was isolated by extraction
with Et2O. After drying (Na2SO4) and removal of the solvent, the crude
1
product was analyzed by H NMR spectroscopy and HPLC.
Dissolution of synthetic oligonucleotides: The synthetic oligonucleotides
were obtained from BioTez. The lyophilized powders were dissolved in
MOPS buffer (20 mm, pH 6.5) and the solution was heated to 948C,
slowly cooled to 58C, and left for 2 h at 58C prior to use. The concentra-
tion was determined by UV/Vis spectrophotometry at 258C.
Reactions in the presence of synthetic oligonucleotides: A 2 mL Eppen-
dorf container was loaded with oligomer solution (400 mL, 2 mgmLꢁ1) in
buffer (20 mm MOPS, pH 6.5), [CuL1ACHTNUGTRNEUNG(NO3)2] complex (200 mL, 0.3 mm),
9602
ꢀ 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2009, 15, 9596 – 9605